1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	c-fos	c-fos	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	c-jun	c-jun	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	jun	jun	_	_	_	_	_	_	_
8	B	b	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	peripheral	peripheral	_	_	_	_	_	_	_
11	blood	blood	_	_	_	_	_	_	_
12	lymphocytes	lymphocyte	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	young	young	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	elderly	elderly	_	_	_	_	_	_	_
17	adults	adult	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	c-fos	c-fos	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	c-jun	c-jun	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	jun	jun	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	proto-oncogenes	proto-oncogene	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	studied	study	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	phytohemagglutinin	phytohemagglutinin	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	PHA	PHA	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	peripheral	peripheral	_	_	_	_	_	_	_
20	blood	blood	_	_	_	_	_	_	_
21	lymphocytes	lymphocyte	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	PBL	PBL	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	from	from	_	_	_	_	_	_	_
26	young	young	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	aged	aged	_	_	_	_	_	_	_
29	humans	human	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Specific	specific	_	_	_	_	_	_	_
2	mRNAs	mrna	_	_	_	_	_	_	_
3	for	for	_	_	_	_	_	_	_
4	c-fos	c-fos	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	c-jun	c-jun	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	detectable	detectable	_	_	_	_	_	_	_
9	within	within	_	_	_	_	_	_	_
10	30	30	_	_	_	_	_	_	_
11	min	min	_	_	_	_	_	_	_
12	after	after	_	_	_	_	_	_	_
13	cell	cell	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	reached	reach	_	_	_	_	_	_	_
17	maximal	maximal	_	_	_	_	_	_	_
18	levels	level	_	_	_	_	_	_	_
19	within	within	_	_	_	_	_	_	_
20	2	2	_	_	_	_	_	_	_
21	h	h	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	c-fos	c-fos	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	jun	jun	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	mRNAs	mrna	_	_	_	_	_	_	_
7	decreased	decrease	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	pre-activation	pre-activation	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	within	within	_	_	_	_	_	_	_
12	6	6	_	_	_	_	_	_	_
13	h	h	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	while	while	_	_	_	_	_	_	_
16	c-jun	c-jun	_	_	_	_	_	_	_
17	mRNA	mRNA	_	_	_	_	_	_	_
18	remained	remain	_	_	_	_	_	_	_
19	elevated	elevated	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	PHA-activated	pha-activated	_	_	_	_	_	_	_
3	PBL	PBL	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	no	no	_	_	_	_	_	_	_
6	age-related	age-related	_	_	_	_	_	_	_
7	differences	difference	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	observed	observe	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	c-fos	c-fos	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	jun	jun	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	mRNA	mRNA	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	c-jun	c-jun	_	_	_	_	_	_	_
4	mRNA	mrna	_	_	_	_	_	_	_
5	levels	level	_	_	_	_	_	_	_
6	decreased	decrease	_	_	_	_	_	_	_
7	significantly	significantly	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	1.73	1.73	_	_	_	_	_	_	_
10	+/-	+/-	_	_	_	_	_	_	_
11	0.08	0.08	_	_	_	_	_	_	_
12	vs.	vs.	_	_	_	_	_	_	_
13	1.16	1.16	_	_	_	_	_	_	_
14	+/-	+/-	_	_	_	_	_	_	_
15	0.09	0.09	_	_	_	_	_	_	_
16	arbitrary	arbitrary	_	_	_	_	_	_	_
17	units	unit	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	P	p	_	_	_	_	_	_	_
20	<	<	_	_	_	_	_	_	_
21	0.01	0.01	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	young	young	_	_	_	_	_	_	_
24	vs.	vs.	_	_	_	_	_	_	_
25	old	old	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	PBL	PBL	_	_	_	_	_	_	_
29	from	from	_	_	_	_	_	_	_
30	elderly	elderly	_	_	_	_	_	_	_
31	individuals	individual	_	_	_	_	_	_	_
32	activated	activate	_	_	_	_	_	_	_
33	with	with	_	_	_	_	_	_	_
34	PHA	PHA	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	Because	because	_	_	_	_	_	_	_
2	previous	previous	_	_	_	_	_	_	_
3	work	work	_	_	_	_	_	_	_
4	has	have	_	_	_	_	_	_	_
5	demonstrated	demonstrate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	from	from	_	_	_	_	_	_	_
10	elderly	elderly	_	_	_	_	_	_	_
11	individuals	individual	_	_	_	_	_	_	_
12	may	may	_	_	_	_	_	_	_
13	display	display	_	_	_	_	_	_	_
14	normal	normal	_	_	_	_	_	_	_
15	proliferative	proliferative	_	_	_	_	_	_	_
16	responses	response	_	_	_	_	_	_	_
17	when	when	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	via	via	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	anti-CD2	anti-cd2	_	_	_	_	_	_	_
22	pathway	pathway	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	c-jun	c-jun	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	jun	jun	_	_	_	_	_	_	_
27	B	B	_	_	_	_	_	_	_
28	mRNA	mRNA	_	_	_	_	_	_	_
29	expression	expression	_	_	_	_	_	_	_
30	was	be	_	_	_	_	_	_	_
31	also	also	_	_	_	_	_	_	_
32	studied	study	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	anti-CD2-activated	anti-cd2-activated	_	_	_	_	_	_	_
35	purified	purify	_	_	_	_	_	_	_
36	T	t	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	No	no	_	_	_	_	_	_	_
2	age-related	age-related	_	_	_	_	_	_	_
3	differences	difference	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	found	find	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	either	either	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	these	these	_	_	_	_	_	_	_
13	two	two	_	_	_	_	_	_	_
14	proto-oncogenes	proto-oncogene	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	anti-CD2	anti-cd2	_	_	_	_	_	_	_
17	activated	activate	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	decreased	decrease	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	production	production	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	proliferative	proliferative	_	_	_	_	_	_	_
11	response	response	_	_	_	_	_	_	_
12	displayed	display	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	PHA-activated	pha-activated	_	_	_	_	_	_	_
15	PBL	PBL	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	elderly	elderly	_	_	_	_	_	_	_
18	adults	adult	_	_	_	_	_	_	_
19	may	may	_	_	_	_	_	_	_
20	be	be	_	_	_	_	_	_	_
21	related	related	_	_	_	_	_	_	_
22	to	to	_	_	_	_	_	_	_
23	age-related	age-related	_	_	_	_	_	_	_
24	changes	change	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	c-jun	c-jun	_	_	_	_	_	_	_
27	mRNA	mrna	_	_	_	_	_	_	_
28	expression	expression	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	ratio	ratio	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	c-fos	c-fos	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	c-jun	c-jun	_	_	_	_	_	_	_
37	mRNA	mrna	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

